Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Electromed ( (ELMD) ) has provided an announcement.
Electromed, Inc. reported strong financial results for the first quarter of fiscal 2026, ending September 30, 2025, marking the twelfth consecutive quarter of year-over-year revenue and net income growth. Net revenues increased by 15.1% to $16.9 million, and net income rose by 44.9% to $2.1 million. The company also completed a manufacturing optimization plan and implemented a new CRM system, enhancing sales productivity and positioning Electromed for future growth. The board approved a $10 million stock repurchase authorization, reflecting confidence in the company’s ongoing performance.
The most recent analyst rating on (ELMD) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on Electromed stock, see the ELMD Stock Forecast page.
Spark’s Take on ELMD Stock
According to Spark, TipRanks’ AI Analyst, ELMD is a Outperform.
Electromed’s strong financial performance and positive earnings call outlook are somewhat offset by bearish technical signals and a moderate valuation. The company’s consistent revenue growth and profitability are significant strengths, but technical analysis indicates potential short-term challenges.
To see Spark’s full report on ELMD stock, click here.
More about Electromed
Electromed, Inc., headquartered in New Prague, Minnesota, is a leader in innovative airway clearance technologies. The company manufactures, markets, and sells products such as the SmartVest® Airway Clearance System, which provides therapy for patients with compromised pulmonary function.
Average Trading Volume: 63,644
Technical Sentiment Signal: Strong Buy
Current Market Cap: $202.9M
See more data about ELMD stock on TipRanks’ Stock Analysis page.